ChiCTR1900027222
尚未开始
/
/
/
2019-11-05
/
/
抑郁症
An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience
An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience
350000
To bridge the knowledge gap to understand TCM theories of depression using neurophysiological biomarkers
随机平行对照
其它
we will recruit research associates to randomize the patients by computer software.
Open label
香港理工大學康復科學系
/
90
/
2020-10-16
2021-10-16
/
1. Aged 18-65 years; 2. Gender: females and males; 3. Western diagnosis: Diagnosed to be suffering from current episode of depression by a psychiatrist based on DSM-5 and subject to verification by Structured Clinical Interview for DSM-5 (SCID-5); 4. Baseline score of 12 or higher on the 17-item Hamilton Rating Scale for Depression (HAM-D17) (29); 5. Traditional Chinese medicine diagnosis: Diagnosed to be experienced the syndromes of liver Qi stagnation by International Medicine of Traditional Chinese Medicine; 6. The Montreal Cognitive Assessment (MoCA) of 20 or higher (30, 31); 7. Patients type: Day- and out-patient; 8. Voluntarily agree with the investigation and willing to sign a written informed consent form.；
登录查看1. Primary diagnosis other than depression; 2. Pregnant or lactating women; 3. Have substance abuse or drug dependence; 4. Acute suicidal or violent behavior; 5. Regular practice of Baduanjin or any kinds of mind-body exercise in the past 6 months (29); 6. Are not able to participant in Baduanjin exercise due to mobility problem.；
登录查看香港理工大學康復科學系
/
药明康德2024-10-25
药渡2024-10-25
医麦客2024-10-25
小药说药2024-10-25
触界生物2024-10-24
磐霖资本2024-10-24
Pharma CMC2024-10-24
Pharma CMC2024-10-24
瑞博小核酸2024-10-24
君实医学2024-10-24
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
